Green Thumb Industries Inc. (OTCMKTS:GTBIF - Free Report) - Equities research analysts at Roth Capital lowered their Q1 2025 EPS estimates for Green Thumb Industries in a research note issued to investors on Thursday, February 27th. Roth Capital analyst W. Kirk now forecasts that the company will post earnings per share of $0.06 for the quarter, down from their previous forecast of $0.07. Roth Capital has a "Strong-Buy" rating on the stock. The consensus estimate for Green Thumb Industries' current full-year earnings is $0.32 per share. Roth Capital also issued estimates for Green Thumb Industries' Q2 2025 earnings at $0.07 EPS, Q3 2025 earnings at $0.06 EPS, Q4 2025 earnings at $0.07 EPS, FY2025 earnings at $0.26 EPS and FY2026 earnings at $0.28 EPS.
Green Thumb Industries Stock Performance
Shares of OTCMKTS:GTBIF traded down $0.25 during mid-day trading on Monday, reaching $6.87. 259,432 shares of the company's stock were exchanged, compared to its average volume of 492,878. The firm has a market capitalization of $1.46 billion, a price-to-earnings ratio of 28.63 and a beta of 1.30. Green Thumb Industries has a twelve month low of $6.08 and a twelve month high of $16.33. The business's fifty day moving average price is $7.29 and its 200-day moving average price is $8.87.
Green Thumb Industries (OTCMKTS:GTBIF - Get Free Report) last posted its quarterly earnings results on Wednesday, February 26th. The company reported $0.04 EPS for the quarter, missing analysts' consensus estimates of $0.06 by ($0.02). The business had revenue of $294.32 million for the quarter, compared to analyst estimates of $289.66 million. Green Thumb Industries had a return on equity of 3.39% and a net margin of 5.38%.
Green Thumb Industries Company Profile
(
Get Free Report)
Green Thumb Industries Inc manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM brands.
Further Reading
Before you consider Green Thumb Industries, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Green Thumb Industries wasn't on the list.
While Green Thumb Industries currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
